Aurobindo Pharma receives US FDA nod for metered Beclomethasone Dipropionate aerosol

As reported by Share Market Today

Aurobindo Pharma said that it has received final approval from the US Food & Drug Administration (US FDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Share Market Today ↗

Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.

INDIAN Quote of the day by Edwin Lefevre: "It is only fair to admit that the commonest and most expensive blunder that all exceptionally brilliant business men make is being right too soon" Markets-Economic Times
INDIAN Rupee slumps 38 paise to close at 95.92 against US dollar Markets-Economic Times
INDIAN Why does the US bond selloff matter for global markets? Markets-Economic Times
INDIAN Bitcoin trades near $77,000 range as investors await US Fed’s September rate decision Markets-Economic Times
COMPANIES Valuation Check: 9 midcap stocks trading well above Industry PE Stocks-Markets-Economic Times
INDIAN Global Market: Bank of Korea signals caution ahead after split rate vote Markets-Economic Times
COMPANIES Sensex crashes over 1,400 pts from day’s high, Nifty below 23,150. 5 triggers behind Rs 9L cr wipeout Stocks-Markets-Economic Times
INDIAN Global Market: Morgan Stanley turns hawkish, sees two Fed rate hikes in 2026 Markets-Economic Times

Aurobindo Pharma receives US FDA nod for metered Beclomethasone Dipropionate aerosol

More from Market Samachar